Cigna sues CVS, former pharmacy head Bricker over exec’s departure

Stolen Credentials and Valid Account Abuse Fuel the Financially Motivated Attacks

Throughout the first half of 2025, financially motivated threat actors have shifted their approach to intrusions, abandoning traditional implant-heavy methods in favor of a more

Beware of Malicious ChatGPT Apps That Records Users Action and Steals Sensitive Data

The explosive growth of artificial intelligence has created an unexpected security threat as cybercriminals exploit ChatGPT’s popularity through counterfeit mobile applications. Recent security research uncovered

OpenAI Unveils Aardvark: GPT-5 Agent That Finds and Fixes Code Flaws Automatically

OpenAI has announced the launch of an “agentic security researcher” that’s powered by its GPT-5 large language model (LLM) and is programmed to emulate a

Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease

The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editing therapy for transthyretin amyloidosis. Nex-z uses the CRISPR

News and Analysis

Subscribe to newsletter

More Posts

Stolen Credentials and Valid Account Abuse Fuel the Financially Motivated Attacks

Beware of Malicious ChatGPT Apps That Records Users Action and Steals Sensitive Data

OpenAI Unveils Aardvark: GPT-5 Agent That Finds and Fixes Code Flaws Automatically

Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company